Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Karp, JE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 40 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Karp, JE; Kaufmann, SH; Adjei, AA; Lancet, JE; Wright, JJ; End, DW
      Current status of clinical trials of farnesyltransferase inhibitors

      CURRENT OPINION IN ONCOLOGY
    2. Karp, JE
      MDR modulation in acute myelogenous leukemia: is it dead?

      LEUKEMIA
    3. Karp, JE; Lancet, JE; Kaufmann, SH; End, DW; Wright, JJ; Bol, K; Horak, I; Tidwell, ML; Liesveld, J; Kottke, TJ; Ange, D; Buddharaju, L; Gojo, I; Highsmith, WE; Belly, RT; Hohl, RJ; Rybak, ME; Thibault, A; Rosenblatt, J
      Clinical and biologic activity of the farnesyltransferase inhibitor R115777 in adults with refractory and relapsed acute leukemias: a phase 1 clinical-laboratory correlative trial

      BLOOD
    4. Brodsky, RA; Sensenbrenner, LL; Smith, BD; Dorr, D; Seaman, PJ; Lee, SM; Karp, JE; Brodsky, I; Jones, RJ
      Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia

      ANNALS OF INTERNAL MEDICINE
    5. Sarkodee-Adoo, CB; Merz, WG; Karp, JE
      Management of infections in patients with acute leukemia

      ONCOLOGY-NEW YORK
    6. Haga, SB; Fu, S; Karp, JE; Ross, DD; Williams, DM; Hankins, WD; Behm, F; Ruscetti, FW; Chang, M; Smith, BD; Becton, D; Raimondi, SC; Berg, PE
      BP1, a new homeobox gene, is frequently expressed in acute leukemias

      LEUKEMIA
    7. Karp, JE; Sarkodee-Adoo, CB
      Therapy-related acute leukemia

      CLINICS IN LABORATORY MEDICINE
    8. Svingen, PA; Karp, JE; Krajewski, S; Mesner, PW; Gore, SD; Burke, PJ; Reed, JC; Lazebnik, YA; Kaufmann, SH
      Evaluation of Apaf-1 and procaspases-2,-3,-7,-8, and-9 as potential prognostic markers in acute leukemia

      BLOOD
    9. Ross, DD; Karp, JE; Chen, TT; Doyle, LA
      Expression of breast cancer resistance protein in blast cells from patients with acute leukemia

      BLOOD
    10. Samaniego, F; Bryant, JL; Liu, N; Karp, JE; Sabichi, AL; Thierry, A; Lunardi-Iskandar, Y; Gallo, RC
      Induction of programmed cell death in Kaposi's sarcoma cells by preparations of human chorionic gonadotropin

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    11. Karp, JE; Blattner, WA
      Immunosuppression, infection, and cancer

      MICROBES AND MALIGNANCY
    12. Karp, JE; Merz, WG
      Response: Randomized trial of lipid-based amphotericin B for invasive aspergillosis in neutropenic hosts is an important step forward

      CLINICAL INFECTIOUS DISEASES
    13. KAUFMANN SH; GORE SD; MILLER CB; JONES RJ; ZWELLING LA; SCHNEIDER E; BURKE PJ; KARP JE
      TOPOISOMERASE-II AND THE RESPONSE TO ANTILEUKEMIC THERAPY

      Leukemia & lymphoma
    14. KAUFMANN SH; KARP JE; SVINGEN PA; KRAJEWSKI S; BURKE PJ; GORE SD; REED JC
      ELEVATED EXPRESSION OF THE APOPTOTIC REGULATOR MCL-1 AT THE TIME OF LEUKEMIC RELAPSE

      Blood
    15. KAUFMANN SH; KARP JE; BURKE PJ; GORE SD
      ADDITION OF ETOPOSIDE TO INITIAL THERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A COMBINED CLINICAL AND LABORATORY STUDY (VOL 23, PG 71, PG 1996)

      Leukemia & lymphoma
    16. KARP JE
      ACUTE-LEUKEMIA - MECHANISMS OF CELL-SURVIVAL AS TARGETS FOR THERAPY (REVIEW)

      International journal of oncology
    17. KELLOFF GJ; HAWK ET; KARP JE; CROWELL JA; BOONE CW; STEELE VE; LUBET RA; SIGMAN CC
      PROGRESS IN CLINICAL CHEMOPREVENTION

      Seminars in oncology
    18. KARP JE; SMITH MA
      THE MOLECULAR PATHOGENESIS OF TREATMENT-INDUCED (SECONDARY) LEUKEMIAS- FOUNDATIONS FOR TREATMENT AND PREVENTION

      Seminars in oncology
    19. BERG PE; HUGUENIN S; RUSCETTI FW; KARP JE; ROSS DD; HAGA S
      BP1, A NEW HOMEOBOX GENE, IS ABERRANTLY EXPRESSED IN ACUTE LEUKEMIAS

      Blood
    20. SOTOMAYOR EM; PIANTADOSI S; MILLER CB; KARP JE; KAUFMANN SH; BRAINE H; HUMPHREY RL; BURKE PJ; GORE SD
      LONG-TERM FOLLOW-UP OF INTENSIVE, ARA-C-BASED CHEMOTHERAPY FOLLOWED BY BONE-MARROW TRANSPLANTATION (BMT) FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - IMPROVED SURVIVAL WITH ALLOGENEIC, BUT NOT AUTOLOGOUS BMT

      Blood
    21. KAUFMANN SH; KARP JE; BURKE PJ; GORE SD
      ADDITION OF ETOPOSIDE TO INITIAL THERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A COMBINED CLINICAL AND LABORATORY STUDY

      Leukemia & lymphoma
    22. KARP JE; PLUDA JM; YARCHOAN R
      AIDS-RELATED KAPOSIS-SARCOMA - A TEMPLATE FOR THE TRANSLATION OF MOLECULAR PATHOGENESIS AND TARGETED THERAPEUTIC APPROACHES

      Hematology/oncology clinics of North America
    23. KARP JE; CHIARODO A; BRAWLEY O; KELLOFF GJ
      PROSTATE-CANCER PREVENTION - INVESTIGATIONAL APPROACHES AND OPPORTUNITIES

      Cancer research
    24. SMITH MA; MCCAFFREY RP; KARP JE
      THE SECONDARY LEUKEMIAS - CHALLENGES AND RESEARCH DIRECTIONS

      Journal of the National Cancer Institute
    25. KARP JE; SMITH MA
      MODIFYING RISKS OF SECONDARY LEUKEMIAS - IS DRUG SCHEDULING IMPORTANT

      Journal of the National Cancer Institute
    26. KARP JE; BRODER S
      MOLECULAR FOUNDATIONS OF CANCER - NEW TARGETS FOR INTERVENTION

      Nature medicine
    27. BRODER S; KARP JE
      PROGRESS AGAINST CANCER

      Journal of cancer research and clinical oncology
    28. KAUFMANN SH; CHARRON M; BURKE PJ; KARP JE
      CHANGES IN TOPOISOMERASE-I LEVELS AND LOCALIZATION DURING MYELOID MATURATION IN-VITRO AND IN-VIVO

      Cancer research
    29. SCHNEIDER E; COWAN KH; BADER H; TOOMEY S; SCHWARTZ GN; KARP JE; BURKE PJ; KAUFMANN SH
      INCREASED EXPRESSION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN GENE IN RELAPSED ACUTE-LEUKEMIA

      Blood
    30. KARP JE; MERZ WG; DICK JD
      MANAGEMENT OF INFECTIONS IN NEUTROPENIC PATIENTS - NEW OPPORTUNITIES AND EMERGING CHALLENGES

      Current opinion in infectious diseases
    31. KARP JE; BRODER S
      ONCOLOGY AND HEMATOLOGY

      JAMA, the journal of the American Medical Association
    32. KARP JE; BRODER S
      NEW DIRECTIONS IN MOLECULAR MEDICINE

      Cancer research
    33. GELLER RB; KARP JE
      ADULT ACUTE-LEUKEMIA - A NEED FOR CONTINUED TRANSLATIONAL RESEARCH

      Blood
    34. KAUFMANN SH; KARP JE; JONES RJ; MILLER CB; SCHNEIDER E; ZWELLING LA; COWAN K; WENDEL K; BURKE PJ
      TOPOISOMERASE-II LEVELS AND DRUG-SENSITIVITY IN ADULT ACUTE MYELOGENOUS LEUKEMIA

      Blood
    35. KARP JE; MCCAFFREY RP
      NEW AVENUES OF TRANSLATIONAL RESEARCH IN LEUKEMIA AND LYMPHOMA - OUTGROWTH OF A LEUKEMIA-SOCIETY-OF-AMERICA NATIONAL-CANCER-INSTITUTE WORKSHOP

      Journal of the National Cancer Institute
    36. KARP JE; MERZ WG; DICK JD
      MANAGEMENT OF INFECTIONS IN NEUTROPENIC PATIENTS - ADVANCES IN THERAPY AND PREVENTION

      Current opinion in infectious diseases
    37. PLUDA JM; VENZON DJ; TOSATO G; LIETZAU J; WYVILL K; NELSON DL; JAFFE ES; KARP JE; BRODER S; YARCHOAN R
      PARAMETERS AFFECTING THE DEVELOPMENT OF NON-HODGKINS-LYMPHOMA IN PATIENTS WITH SEVERE HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION RECEIVING ANTIRETROVIRAL THERAPY

      Journal of clinical oncology
    38. WINGARD JR; MERZ WG; RINALDI MG; MILLER CB; KARP JE; SARAL R
      ASSOCIATION OF TORULOPSIS-GLABRATA INFECTIONS WITH FLUCONAZOLE PROPHYLAXIS IN NEUTROPENIC BONE-MARROW TRANSPLANT PATIENTS

      Antimicrobial agents and chemotherapy
    39. GORE SD; KARP JE; MILLER CB; BRAINE HL; HUMPHREY RL; KAUFMANN S; TUCKER RA; BURKE PJ
      BRIEF INTENSIVE THERAPY FOR ADULT ACUTE LYMPHOCYTIC-LEUKEMIA (ALL) - SUPERIORITY OF ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)

      Blood
    40. KARP JE
      STAT BITE - AIDS-RELATED CANCERS IN YOUNG WHITE MEN

      Journal of the National Cancer Institute


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 15:32:04